Point72 Asset Management, L.P.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Jun 30, 2026CallValue
$1,996,995
CallShares
24,500
PutValue
$1,255,254
PutShares
15,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ARWR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,255,254 | 15,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,996,995 | 24,500 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $721,050 | 11,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $2,188,230 | 34,900 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,799,169 | 27,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $318,672 | 4,800 | Put | Defined | 2026-02-17 | |
| 2023-09-30 | $21,791 | 811 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,379 | 908 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $2,297,805 | 56,652 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $22,031,130 | 666,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,938,512 | 395,868 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $25,804,989 | 561,100 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,936,559 | 44,292 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,020,015 | 160,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,629,638 | 55,900 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $57,394,630 | 1,332,899 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $51,387,764 | 1,189,807 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||